Method in the treatment of schizophrenia
US6468973B1 · kind B1 · utility
0Cited by
2References
20Claims
0Family size
Inventor
Key dates
| Filing date | Jun 4, 2001 |
| Grant date | Oct 22, 2002 |
| Priority date | — |
| Expiry date | Jun 4, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a composition comprising at least one substance within the group GnRH-analogues for producing a drug for treatment of schizophrenia. The invention makes it possible for patients suffering from schizophrenia to obtain partial or total relief of symptoms by treatment with a composition which comprises at least one substance within the group GnRH-analogues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.